The Digital Personal Data Protection Act,2023 (DPDPA,2023) would hypothetically serve as a comprehensive framework for data protection in India, impacting various sectors including Life Sciences. The act is aligned with global standards like GDPR, focusing on the ethical and secure handling of personal data.
These regulations place specific legal responsibilities on numerous organisations in the life sciences sector, dictating how they should handle, transfer, and manage personal data.
The ever-evolving landscape of pharmaceutical, therapeutic, biotechnological, and medical device research and development has underscored the critical importance of implementing strong data protection measures.
Given the sensitive nature of research and clinical trials, robust data protection measures are crucial in the Life Sciences sector, the key points would be as under;
The obligations that Medical and Healthcare organisations must adhere to:
✔️ Maintain transparency in the handling and processing of personal data.
✔️ Be well-versed in the prerequisites for data processing and the safeguards needed for data transfer.
✔️ Adopt suitable technical and organisational safeguards to secure personal data.
✔️ Gain a comprehensive understanding of the types of personal data being processed, who can access it, and the scope of international data transfers.
✔️ Promptly identify, address, and, when required, report any data breaches.
✔️ Acquaint yourself with the regulations set forth towards the Clinical Trials and ensure data protection compliance under these rules.
✔️ If applicable, designate a Data Protection Officer in India and also representatives in the EU and UK.
✔️ Establish proper agreements between each data controller and data processor involved in the handling of your personal data.
This list aims to provide a comprehensive guide for Life Sciences organisations to ensure they are in compliance with data protection laws and regulations.